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Enumeration of bacteria has been the subject of research for over a century. Some of the 
techniques that have been developed include viable plate counts, the most probable number 
assessment, and more modern molecular techniques. Many of the newer molecular-based 
techniques provide little or no information about the viability of the cells being counted, and are 
generally not quantitative. Having quantitative data for potentially pathogenic bacteria on 
surfaces can be very useful in many settings, particularly in healthcare facilities. Knowing the 
numbers of bacterial cells present on surfaces within healthcare facilities may be important to 
attempt to study the cause of healthcare associated infections (HAIs).  This study was envisioned 
to help develop a rapid technique to quantify viable bacteria utilizing a short (5 cm) line 
inoculation on agar-based growth media, providing a quick assessment of the density of bacterial 
cells present. To do this required determination of the relationship between colony counts from 
line inoculations compared with viable plate counts from the same source of bacterial cells. This 
study of Escherichia coli and Staphylococcus aureus has produced data that suggests that there is 
a close relationship between the number of cells placed on a microscope slide and the colony 
counts obtained from swabs used to remove those cells from the slide, whether counted by a 
viable plate count or via a short line inoculation on an agar surface. When the number of colony 
forming units (CFUs) on the microscope slide are < 5000 for E. coli, and < 10,000 for S. aureus 
there is good correlation between the viable plate count and the line inoculation count. This 
relationship between the numbers of colonies in the starting material surface and the line 
inoculation falls off when the numbers of colonies from the source material (the microscope 
slide) is greater. Factors that may contribute to this loss of correlation when the source material 
has higher numbers of CFUs may include surface area issues similar to limitations to statistically 
valid viable plate counts that have been known for a century. The results of this work should lead 
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to additional studies with different species of bacteria, as this study only included one Gram-
positive, non-motile coccus (S. aureus) and one Gram-negative, motile rod (E. coli). Other 





Background and Introduction  
1.1       Literature Review  
It is important to be able to enumerate bacteria efficiently, accurately, and cost-
effectively from environmental samples.  This is especially true when examining and 
enumerating samples from healthcare settings.  Many enumeration techniques are either 
expensive, time-intensive, or labor intensive.  Techniques such as real-time PCR (RTPCR) or 
Quantitative PCR (QPCR) are very specific and accurate for specific bacterial species.  
However, the issue lies with viability and the means through which this technique enumerates 
bacterial cells (as gene-count, which requires a separate calibration).  This study aims to calibrate 
a short line (5 cm) inoculation technique developed by the University of Tennessee at 
Chattanooga’s Clinical Infectious Disease Control research group (CIDC) to rapidly enumerate 
bacterial contamination on surfaces in healthcare facilities.  With this technique, surfaces are 
swabbed, the swabs are transported to the CIDC lab on ice where they are then used for a short-
line inoculation on an agar plate. Through the use of different types of agar-based media (e.g., 
selective and differential, or simply non-selective) different types of bacteria can be identified 
and enumerated.  After the inoculated colonies have grown up and are counted, a density of 
contamination score can be given for the swabbed sites.  This calibration study was necessary in 
order to provide data to link the density of contamination scores to the much more commonly 
utilized results of viable plate counts in Colony Forming Units (CFUs).  This provides a fast and 
cost-effective way of enumerating viable bacteria.  However, it is important to examine other 
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enumeration techniques available, which offer different types of data that might be important in 
differing ways. 
One of the oldest techniques used to enumerate bacteria is the most probable number 
(MPN) estimate of bacterial numbers in aquatic samples. Developed to study water quality, the 
original MPN tests focused on counting coliform bacteria through the use of a lactose broth 
medium, and a multiple tube inoculation to determine fermentation of the lactose (Galvin 2010).  
To provide quantitative data, this MPN technique requires a complex statistical treatment of the 
results obtained to yield a “MPN” index per 100 ml for the initial aquatic sample. The MPN 
technique is still utilized for many studies. Recently, Galvin et al. (2010) sampled effluent wastes 
from hospitals and other clinical sites to determine the most probable number (MPN) of E. coli 
and the percentage of that bacteria that was antimicrobial resistant.  They created a commercial 
MPN technique to enumerate how many E. coli isolates were resistant to specific antimicrobial 
agents.  While this form of bacterial enumeration is based on an older technique, these 
researchers modified the technique to focus more on antimicrobial resistance. Although 
providing new data, the basic MPN technique used remains a very labor, materials, and time 
intensive procedure.   
Another group of researchers at a hospital in Winnipeg, Canada developed a modified 
enumeration technique that combined two separate older techniques (Warner and Glassco 1963). 
One of the methods they used involved setting agar plates of various media types with the lid off 
on the floor to allow airborne bacteria to land on the plates.  The plates were left out for several 
hours. The second method was using a Bourdillon “small” slit air sampler in 5-minute 
increments.  The data between the two techniques varied, but was similar to previous published 
articles using the same methods.  However, when numbers generated by their technique were 
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compared with the number of hospital infections in a unit of that hospital, little agreement 
between bacterial numbers from their work and the numbers of infections was found.  While this 
was an attempt to enumerate bacteria in a clinical hospital setting, it used techniques that 
apparently did not generate data that might have been useful in a discussion of hospital 
infections. Today we know that studies of bacterial contamination of environmental surfaces in 
healthcare facilities suggest that enumeration of bacteria on high-touch surfaces or the floors 
may prove much more important (Han 2015).   
Many new techniques to enumerate of bacteria have been developed. One field of study 
where innovative enumeration techniques have been developed is the food industry.  Although 
the target of these enumerations is very different from a clinical setting, these techniques are 
useful in examining many species of bacteria that are potentially pathogenic that may be found in 
foods.  According to Gracias and McKillip (2004), many laboratories depend on typical 
microbiology techniques such as viable plate counts when looking for bacterial contamination of 
foods.  This is due to the complexity, cost, and accuracy of other techniques.  One modification 
of the viable plate count technique used with foods is the addition of a selective layer of agar on 
top of nonselective media such as tryptic soy agar (TSA) for viable plate counts.  This selective 
layer enriches isolation of targeted bacteria by increasing the sensitivity of the media.  This 
technique is a lower cost method than modern molecular tests, and in addition provides data on 
viability of bacteria found in the foods.  However, this still requires the use of serial dilutions 
which can be time, materials, and labor intensive.  A similar technique is to use specific selective 
media for plating such as XGAL, CHROMagar, and Colilert.  These different types of media are 
extremely useful due to the target species they will allow to grow, but again a serial dilution is 
still required in order to inoculate the media. As noted above, the CIDC has modified the 
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inoculation of media like these through the use of line inoculations. The short-line inoculation 
technique can allow the use of eight swab samples per plate, increasing the cost-effectiveness of 
the process.   
Other techniques used to identify bacteria from many different types of samples include 
metabolic tests. Although not readily used for enumeration, specific utilization of sugars, amino 
acids, and other nutrients have been used with environmental samples to identify the presence or 
absence of specific species of bacteria (Talaiekhozani et al. 2015). These techniques most often 
require the use of pure cultures, which inserts another step into the process.  Additionally, these 
technique are time and labor intensive. Based on a requirement for pure cultures, other methods 
that enable identification of bacterial species, but not necessarily their numbers include: 
immunomagnetic separation (IMS), enzyme-linked immunosorbent assay (ELISA), and ATP 
bioluminescence assay (Gracias 2004).  In order to make many of these identification tests 
quantitative, it would be possible to set up tests following a MPN design. However, to do this 
would add a great deal of cost, time, materials, and labor.   
Utilization of viable plate count technology in other, novel ways to enumerate bacteria 
has led to other new techniques. One of these is the drop plate technique. This technique, like the 
standard viable plate count method, uses a serial dilution and plating. The standard technique is 
to dilute and place a 100µl aliquot onto an agar plate and spread it. The drop plate technique 
places a “drop” of 10 µl onto an agar plate which is allowed to dry into the agar.  One of the 
benefits of this technique is that the same plate can be used for multiple drops, which saves time 
and money.  Some data using this drop test suggests that this technique is just as accurate as the 
standard viable plate count procedure, but it has not yet been fully adopted (Naghili et al. 2013). 
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An entirely different group of tests to enumerate bacteria from environmental samples 
has been developed using molecular techniques. Essentially, these tests require the extraction of 
DNA from the samples, with further work required to identify specific genes on this DNA. Much 
like the biochemical tests used to identify bacteria discussed earlier, determination of the 
presence or absence of genes from DNA, does not enumerate the bacteria present. Through the 
use of the Polymerase Chain Reaction (PCR), specific genes can be amplified if the appropriate 
primers are used in the process. Modifications to the PCR process developed in the early 2000s 
resulted in a process that will count gene-copy as the amplification process goes through 
sequential cycles (Zhu 2020). This technique, quantitative real-time PCR (QPCR or RT-PCR), 
produces gene-copy numbers based on the original starting DNA sample.  Brinkman et al. (2003) 
utilized QPCR to evaluate six species of the yeast Candida sp. for water samples collected from 
Lake Michigan.  First, the researchers had to create a stock culture to calibrate the QPCR. This 
involved using a mini bead-beater and centrifuging the yeast to isolate the genomic DNA.  Next, 
a primer and probe set had to be developed to target the specific yeast species.  The QPCR 
method also has a minimum gene detection limit for each yeast species.  These detection limits 
had to be determined prior to using the Lake Michigan water samples (Brinkman 2003).  It is 
important to recognize that the QPCR method was used for water samples rather than in a 
healthcare setting. González et al. (2003) have used QPCR to enumerate acetic acid bacteria 
from environmental samples. However, these studies demonstrate the time intensive nature of the 
QPCR method.  While it has high specificity and accuracy for quantification when properly 
calibrated, the method is very complex, costly, and requires a lot of time intensive preparation. 
Another problem that QPCR has when enumerating bacteria from environmental samples is the 
fact that QPCR data provides no indication whether the DNA from the sample came from viable 
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bacteria, from dead bacteria, or from unculturable bacteria that may not grow on media used in 
microbiology labs (Li et al 2014, Wade 2002). Questions of viability of bacteria, especially for 
samples from healthcare facilities are of great importance in any studies of HAIs.  
Several of the techniques discussed here have been used for enumerating bacteria in a 
variety of settings.  However, many of them have drawbacks such as time, cost, labor, or 
complexity. An additional issue, particularly with molecular techniques used to enumerate 
bacteria is the fact that the data provided does not necessarily yield evidence of viability of the 
bacteria being identified. Additionally, throughput of large numbers of samples, especially using 
molecular techniques poses problems, including high expenses.  Therefore, the development of 
rapid identification techniques for viable bacterial cultures from environmental samples that also 
provides enumeration could be quite helpful, especially in the healthcare setting. The line 
inoculation technique presented here, with proper calibration can provide data on numbers of 
viable bacteria present in environmental samples. The calibration process discussed here will 
convert the density of contamination scores produced from the colonies found after the line 
inoculations into colony forming units (CFUs). Having such data in units of CFU allows for 
comparison of values from many different settings where viable plate counts have been used to 
enumerate bacteria.  This line inoculation technique is much cheaper, systematic, and capable of 
processing larger amounts of samples than other techniques used previously. 
1.2      Introduction 
Bacteria are occupants of every habitat on Earth.  From deep-sea hydrothermal vents to 
the lining of the human intestines, species of bacteria are found.  This theme is especially true for 
hospitals and other healthcare facilities. A critical health issue in these facilities is healthcare-
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associated infections (HAIs).  According to Wang, et al. (2019), HAIs impact hundreds of 
millions of people each year globally. Primarily, an infected patient is noted to have an HAI 
when the patient has been admitted to the hospital for 48 hours, and the infection was not present 
at the time of admission (Wang 2019).  While hospitals consistently sanitize essential equipment 
and high touch surfaces, bacteria are still found in high numbers on surfaces throughout the 
facilities.   Additionally, this cleaning has not always been effective and may be related to the 
frequency of HAIs annually.  Wang, et al. (2019) provided data on the occurrence of HAIs from 
the World Health Organization (2011) such that high-income countries reported 3.6 to 12% 
incidence and low-middle income countries reported 5.7 to 19.1% (from 1995-2010). Links 
between environmental bacterial contamination in healthcare clinics and HAIs have been 
observed for intensive care units (Shiomori et al. 2001, Adams and Dancer 2020), and may exist 
for other hospital units.  
Pathogen transmission in a clinical setting can occur from numerous different surfaces.    
Surfaces that may play roles in the transfer of pathogens to patients have been the focus of 
research. Donskey (2019) found that portable and shared equipment contributed to the 
dissemination of bacteria throughout the hospital.  This equipment comes into direct and indirect 
contact with patients and the staff which can lead to the transmission of potential pathogens.  
Specifically, it was found that electronic thermometers have the most likely chance as a vector 
for pathogen transmission.  It was noted that other studies have suggested that portable 
equipment can lead to the dissemination of viral DNA markers throughout healthcare facilities, 
including into other wards (Donskey 2019). 
Stationary equipment and high touch surfaces are often cleaned, but contamination can 
still be found on these surfaces.  One study sought to identify hospital floors as a potential source 
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for the circulation of pathogenic bacteria onto high touch surfaces.  In this study, the researchers 
transferred a specific amount of surface area on the floor near patient beds with a nonpathogenic 
virus (a bacterial virus that would not target human cells) as a marker; the objective of this study 
was to evaluate if the virus swabbed on the floor would be transmitted to other surfaces.  The 
virus marker was not only found on the high touch surfaces in the patient’s room but also in 
adjacent rooms and on nursing stations located outside of the patient’s room (Koganti 2016).    
 Concern for contamination of clinic floors has resulted in studies focused on the 
frequency of the isolation of pathogens on surfaces.  Deshpande et al. (2017) examined how 
frequently isolation room floors are contaminated with common healthcare-associated bacterial 
pathogens.  Although it is fairly well-known that floors are highly contaminated, disinfection 
regimens for floors are poor (or even absent entirely) because there is little to no direct patient 
contact with the floors.  However, the researchers found that high-touch objects like medical 
equipment, personal items, and room linens actually often do come into contact with the floors.  
Therefore, the hospital was focusing on cleaning high-touch objects, but these objects were still 
getting contaminated from the floor (Deshpande 2017).  This result is partially due to the lack of 
attention paid to the floors of the hospitals in cleaning protocols used by their staff.  Otter et al. 
(2013) noted that according to recent research, contaminated surfaces are significant factor in the 
transmission of bacteria that can lead to healthcare-associated infections.   
A separate study sought to identify the mechanisms by which floor surfaces or ground 
contamination led to human infection.  The study noted that shoe soles are consistently 
contaminated with infectious bacteria that cause HAIs.  Rashid, et al. (2017) states that upwards 
of 40% of shoe soles found outside of clinical settings are contaminated with Clostridium 
difficile.  Therefore, it is likely that individuals entering a healthcare setting may be introducing 
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potential pathogens via their shoes.  The researchers came to the conclusion that there are direct 
and indirect pathways that lead to contaminated floor surfaces to contact humans.  The direct 
pathways included direct human contact and aerosolization.  Direct human contact is the result of 
patients touching clothing such as socks and shoes that have been in contact with the 
contaminated floor.  Aerosolization is created by individuals walking on the contaminated floor, 
which allows for the microorganisms to become airborne, possibly on dust particles.  The study 
also identified an indirect pathway through arthropod-borne transmission (Rashid 2016).  
Another study focused on the efficacy of a recently developed shoe sole UVC device to lower 
pathogen colonization on floors, surfaces, and patients.  The researchers noted that other studies 
had identified the presence of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-
resistant enterococci (VRE) and multi-drug-resistant Gram-negative bacteria on shoe soles.  The 
researchers added that shoe soles can have a high contamination of bacteria (Rashid 2017). 
Methicillin resistant S. aureus, VRE, and multi-drug-resistant gram-negative bacteria are 
commonly found in clinical settings and are a major cause of HAIs.  A subset of HAIs called 
surgical site infections (SSI) is the second most common HAI behind urinary tract infections.  
Staphylococcus aureus is the most frequently isolated pathogen from SSIs.  The second most 
common was bacteria in the Enterobacteriaceae, with Escherichia coli as the most predominant 
(Cantlon 2006).  This is important to note because, according to Cantlon et al., about 2 million 
patients acquire HAIs each year and about 77,000 of them will die with HAI being the direct 
cause or a contributing factor.  With S. aureus being the predominant pathogen isolated from 
SSIs in this study (and others [Manion 2003, Olson 1990]), it is critical that our study focuses on 
such a widely found pathogen.  Escherichia coli was the second most predominant species 
isolated from SSIs.  In a separate study, E. coli was found to be the seventh most common agent 
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of SSIs (Weiss 1999). Due to its high association with SSIs and being a well-known human 
commensal with a high capacity for pathogenic activity in intestinal surgeries, this study also 
focuses on E. coli.   
This information is important to recognize the hazard that the presence of these 
pathogenic microorganisms in hospital settings provides for healthcare workers and patients.  It 
would seem that studies to enumerate the variety of species of microorganisms that are present in 
healthcare facilities should be routine.  The studies mentioned previously mostly focused on 
bacterial transmission and community structure, rather than enumerating the specific pathogenic 
microorganisms present in/on the specific sites found in the healthcare facilities.  A small 
number of studies actually provide data linked to viable bacterial cell numbers in healthcare 
facilities.  This is due in part to limitations inherent in the laboratory techniques used to evaluate 
the presence or absence of bacterial groups and to enumerate specific species of bacteria in the 
environments. 
Enumeration of viable bacteria requires that some sort of culture-based study be 
conducted. An example of a good way to enumerate viable bacteria is to utilize a viable plate 
count technique, which is practiced widely across the food industry.  To use this technique a 
known quantity of food is extracted, serially diluted, and plated for viable plate counts.  This 
allows the researchers to calculate an estimate of the CFUs in the original food matrix (Bajwa 
2013). Through the use of a serial dilution with plating to an appropriate growth medium, colony 
counts can be obtained. Studies of this nature tend to be time and material consuming. However, 
trying to replace viable plate counts with gene-copy numbers using RT-PCR again brings up the 
question of viability. Work done by Keilman et al. (2021) using a modified agar medium 
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inoculation process and line inoculations, leading to a colony count may help provide a new 
technique to scan hospital environmental surfaces for viable bacterial contaminants.  
  Beginning in 2015, UTC’s Clinical Infectious Disease Control research group (CIDC) 
has sought to survey numerous potentially pathogenic bacteria in outpatient physical therapy 
clinics, as well as in inpatient units in Erlanger Hospital (e.g., Keilman et al. 2021, Spratt et al. 
2014).  In order to provide a rapid assessment of a multitude of samples from the clinics, CIDC 
developed an assessment protocol where transport swabs collected from facility surfaces were 
used to inoculate different types of agar media (selective and differential) with a short line 
inoculation technique.  The amount of bacteria present along the lines of growth after incubation 
is used to determine density of contamination estimates as either “low” (1-5 colonies), “medium” 
(6-15 colonies), or “high” (>15 colonies).  This technique provides a good semi-quantitative 
assessment of pathogens that are present at the locations that they are collected.  However, this 
technique is only minimally quantitative.  
         The objective of this study is to help provide data on the enumeration of two potential 
pathogens, E. coli and S. aureus, linking viable plate counts (CFU) to the density of 
contamination estimates provided by the CIDC’s line inoculation enumeration technique. The 
two bacterial species tested were S. aureus and E. coli. These bacterial species have been chosen 
because they are known occupants of surface environments in Erlanger Hospital and due to their 
relevance as human commensal bacteria or as potential pathogens. Enumeration of these 
bacterial species was done in vitro, using microscope slides coated with known quantities of 
these bacteria as target surfaces. Through the use of swabs to remove the bacteria from the slides, 
enumeration of cells on the swabs and enumeration of bacteria on line inoculations has resulted 
18 
 
in calculation of correction factors for these species to convert density of contamination 





Materials and Methods  
This study was conducted in the Clinical Infectious Disease Control (CIDC) research lab 
in Holt Hall, on the UTC campus (Holt Hall, room #305). Standard microscope slides were 
placed in glass petri dishes and autoclaved to produce uniformly sterile surfaces having the same 
surface areas. Lab strains of S. aureus and E. coli were obtained from the UTC Microbiology 
Prep lab (Traceable to ATCC strain 25922 [E. coli], and ATCC strain 25923 [S. aureus]). These 
cultures were maintained in the CIDC lab using either tryptic soy agar (TSA) or tryptic soy broth 
(TSB), both obtained from Fisher Scientific (Suwanee, GA). Serial dilutions were conducted 
using sterile 0.85% saline, and in some cases in sterile TSB. As serial dilutions were made the 
tubes were stored in an ice bath to arrest their growth. A separate sterile transport swab (with 
liquid Stuart’s medium, Fisherbrand, Fisher Scientific, Suwanee, GA) was used to remove 
bacterial cells from each glass slide onto which the cells had previously been placed and dried 
(see below). 
As noted above, the purpose of this study is to calibrate the line inoculation technique 
with a viable plate count to provide a quicker and more cost-effective way to estimate the CFUs 
of viable bacterial cells present on the sample swabs.  This was done by quantifying bacterial 
cells using viable plate counts of pure cultures of E. coli or S. aureus, which would be used to 
produce known quantities of these bacteria on standardized surfaces (sterile glass microscope 
slides).  To do this a known aliquot (from the 10-3 dilution) of one of the pure cultures was 
placed onto replicated (triplicates) of sterile glass microscope slides.  Two sets of triplicate slides 
were used for each experiment for one pure culture; one set was swabbed to determine the CFUs 
of bacteria placed on the slides.  The second set of replicated slides was used to inoculate a TSA 
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plate using the short (5 cm) line inoculation technique.  The data acquired was used to determine 
an estimate of the CFUs at the initial sample based the number of CFUs produced by the short 
line inoculation.  Using glass microscope slides allowed for a controlled environment where the 
bacteria was dried and swabbed each time.  This study converted the density of contamination 
scores into an estimate of the original CFUs.   
2.1     Materials and Preparation 
As noted above, glass microscope slides were placed inside glass petri dishes and 
sterilized in the autoclave.  These petri dishes were then placed in a drying oven (60 oC) to 
ensure that all of the sterile slides were dry. For each experimental replicate, individual sterile 
slides were aseptically transferred into individual plastic petri dishes. Tryptic soy agar was the 
medium of choice to both grow up the cultures and plate them.  TSA was made by adding TSA 
to distilled water according to the manufacturer’s instructions in a 1L Erlenmeyer flask and 
mixing it thoroughly while on high heat until boiling.  For the TSA slants, boiled aliquots of the 
liquid TSA were transferred into multiple test tubes prior to sterilization in the autoclave.   For 
TSA plates, the 1L flask of boiled TSA was directly autoclaved.  After sterilization, the TSA 
tubes were placed on a slanted surface and allowed to solidify to produce slants.  The TSA in the 
1L flask was poured into pre-sterilized plastic Petri dishes directly after sterilization at about 15 
mL per dish.  The plates were allowed to solidify, stacked and allowed to dehydrate for 2-3 days 
before use.   
Sterile 0.85% NaCl saline was also used in the study.  To make the solution, 8.5 g/l of 
NaCl was added to distilled water in a 1L flask and hand-stirred until all NaCl had dissolved.  
The flask of saline was then autoclaved.  Additionally, sterile TSB was also used for dilutions in 
this study.  To make the TSB solution, TSB was added to distilled water according to the 
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manufacturer’s instructions and stirred at low heat until all of the TSB had dissolved.  The TSB 
was then autoclaved.  Prior to each experiment, the bacterial cultures were grown on TSA slants 
over 48-72 hours at room temperature.  When a 24-hour culture was needed, they were grown at 
37oC.    
2.2     Experimental Design 
To begin an experiment, the selected bacterial culture was grown on a TSA slant over 24-
72 hours at room temperature.  Bacterial cells were removed from the TSA slant by adding 1 
milliliter (mL) of sterile 0.85% NaCl saline using a sterile pipet and teasing the cells off the slant 
to make a suspension.  The 1 mL of solution was then removed from the slant and transferred to 
a sterile test tube.  The general serial dilution scheme for cells present in the suspension from the 
slant is diagramed in Figure 1.  From the bacterial suspension, 0.1 mL was transferred to 9.9 mL 
of sterile tryptic soy broth (TSB), which was kept in an ice bath until it was used later.  Note that 
the diluent used here was TSB and not 0.85% saline.  This was due to the need to have these 
cells suspended in a rich organic mixture (the TSB) to help support their survival after being 
dried down on the surface of sterile microscope slides (see below).  When cells are suspended in 
a rich organic mixture their survival on drying is much greater (Spratt et al., 2019).  This mixture 
was then mixed using a vortex mixer for 15 seconds.  One mL of this mixture was then 
transferred to a test tube containing 9.0 mL of sterile TSB.  This mixture was vortexed for 15 
seconds and 1 mL was transferred to a test tube containing 9.0 mL of sterile 0.85% NaCl saline.  
Once this transfer was complete, the previous tube containing 9.0 mL TSB + bacteria was placed 
on ice to preserve bacteria cells and slow their growth.  This tube (the 10-3 dilution tube) was 
later used to place 0.025 mL aliquots onto glass microscope slides. The remaining 1:10 dilutions 
needed to complete the serial dilution for the viable plate count were made as indicated in Figure 
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1. The serial dilution ran through the 10-7 dilution. For the viable plate counts 0.1 mL from each 
of the 10-5, 10-6, and 10-7 dilutions were plated. Later in the study additional dilutions were added 
to the scheme to produce lower numbers of cells for the aliquot added to the microscope slides.  
For the plating to TSA plates, the desired dilution was vortexed for 15 seconds and 0.1 mL was 
removed.  This aliquot was then placed onto the plate and spread using a spreading rod, 
previously sterilized by flaming with alcohol.   
 
Figure 1: Experimental design scheme used in this study 
 
For a majority of the experiments run for both cultures, the 10-3 dilution was used to 
transfer 0.025ml aliquots onto two triplicates of glass microscope slides.  Use of this dilution of 
cells resulted in a final number of cells being placed on the sterile microscope slide surface from 
2.53x105 to 2.58x103 cfu/ml for E. coli and 4.23x105 to 2.80x103 cfu/ml for S. aureus.  The 10-3 
dilution was removed from the ice bath and was vortexed for 15 seconds for each transfer of 
0.025ml onto the glass microscope slides. The aliquot was placed on the slides and spread 
(“painted”) on the surface to place cells over a uniform surface area, which were then air dried.  
For a typical experiment, the first set of triplicate slides was dried using a stream of filtered air 
for approximately 5 minutes per slide. This first set of slides, once dried, was immediately 
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swabbed using a sterile transport swab to remove as many of the bacteria on the surface of the 
slide as possible, moving and rotating the swab to bring the entire swab surface in contact with 
the surface of the slide.  The used swabs were immediately placed back in their transport tubes 
and stored on ice to ensure high bacterial survival for subsequent steps in the process.  Once 
swabs for three slides were collected, they were later removed from the ice bath and used to 
transfer cells picked up to either sterile saline (for viable plate counts) or for line inoculations on 
TSA (see Figure 1).   
Bacteria picked up by the swabs for enumeration by viable plate counts, were first 
suspended in a tube of 5 ml of sterile saline (see Figure 1).  To accomplish this, the desired swab 
was removed from its protective plastic tube and placed approximately 2 inches into the sterile 
test tube.  Flamed scissors were then used to cut the swab from its shaft, allowing it to drop into 
the TSB. This process took approximately 10 seconds per swab to complete.  The test tube was 
then vigorously mixed using a vortex mixer for 30 seconds to allow for suspension of bacterial 
cells that had been present on the swab surface.  One ml of the mixed TSB + swab was 
transferred to another test tube containing 9.0 ml of sterile saline.  Both tubes were then vortexed 
for 15 seconds and plated (0.1 ml) onto TSA plates and allowed to grow for 48 hours.  E. coli 
was grown at room temperature and S. aureus at 37oC.   
As previously mentioned, further dilution was occasionally required in the initial serial 
dilution to decrease the number of colonies present when the short line inoculation technique was 
used.  One to two extra test tubes of sterile TSB was added between the first 9.9 mL TSB and 9.0 
mL TSB tubes.  The dilution for these extra tube(s) ranged from 1:2, 1:3, 1:5, 1:7, 1:9, 1:10, 
1:2+1:10, 1:5+1:10, and 1:7+ 1:10.  This was necessary due to the original serial dilution scheme 
producing high numbers for the short line inoculation.  To produce lower values that fall within 
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the “low” and “medium” contamination scores, these dilutions were added.  No other aspect of 
the protocol was changed.    
In order to provide a comparison between viable plate counts and the line inoculation 
from glass microscope slides with known quantities of bacteria on them for swabbing and 
transfer to TSA agar using a line inoculation technique (as the CIDC samples are treated), 
another set of triplicated, dried bacterial slides was prepared.  While the first triplicate of slides 
were being processed (and used to count the cells by way of a viable plate count), the second 
triplicate set of slides was being allowed to air dry, using filtered air to complete the process.  
After collecting cells from this second set of slides the swabs were immediately placed on ice.  
Once all three slides were swabbed, they were used to perform the short (5 cm) line inoculation 
onto TSA plates, replicating the technique used by UTC’s CIDC from previous studies at 
Erlanger Hospital.  The inoculated plates were then incubated for 48 hours. E. coli was grown at 
room temperature and S. aureus at 37oC.     
Once grown, colony counts were calculated for both species of bacteria for the two 
different treatment techniques used.  For the line inoculations made on the plates density of 
contamination scores (as used by the CIDC) were generated.  Low densities represented 1-5 
colonies (“Low” contamination), medium densities had 6-15 colonies (“Medium” contamination, 
and high densities had >15 colonies (“High” contamination).  These contamination scores were 
compared to the number of bacteria (via viable plate counts) taken from the first set of 
microscope slides to calibrate the estimation protocol.  To statistically analyze the calibration 
experiments, a Student’s T-test was used on the means of the replicates.   
 
2.3     Calculations and Statistical Analysis  
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 To determine the percent agreement between the line inoculation and colony forming 
units on the swab, viable plate counts from the plated slides had to determined.  This value was 
used to determine how many CFUs/ 5mL was in the TSB suspension after swabbing.  Once this 
value was determined for each triplicated slide, an average was taken.  Next, colonies had to be 
determined for the short line inoculations (see Appendix I).  
 Since swabs were used to transfer bacteria onto the microscope slides and to transfer 
bacteria onto the agar plates via line inoculations, it was important to have a good estimate of the 
surface area of the swabs. A brief search of the literature did not turn up any published work 
focused on transport swab surface area. So, a procedure was developed to calculate the surface 
are of the swabs used. Having knowledge of this surface area was important because in the line 
inoculation only one portion of the swab was brought into contact with the agar as the swab was 
moved approximately 5 cm across the agar surface, although the entire swab was used to pick up 
bacteria from the slides (or from some environmental site). To account for bacteria remaining on 
the swab after a line inoculation the total surface area of swab, and the surface area of the swab 
that comes in contact with the agar should be known. To estimate these surface areas the 
following procedure was used. First, to estimate the surface area of the swab placed in contact 
with the agar surface for a line inoculation one side of a sterile swab was placed onto a glass 
slide without moving it. The wet mark left after the swab was placed on the glass was outlined 
(on the back of the slide) with a Sharpie. Then, to estimate the total swab surface area, a fresh 
swab was first marked with a small black dot on the shaft of the swab. The swab was then placed 
at one end of a new glass slide (with the black dot facing up), and the swab was rolled down the 
slide until the black dot again was facing up. This motion resulted in an elliptical mark on the 
slide, which was then traced with a Sharpie on the back of the slide. Then, to account for the tip 
26 
 
of the swab, the tip of that same swab was placed on an unused portion of the slide to make a 
circular mark on the slide, which was also traced on the back of the slide. The areas of these 
tracings were then calculated, and a correction factor to account for the entire surface area of the 
swab (when used for a line inoculation) was made. The number of colonies counted on the agar 
petri dishes used for the line inoculations were then multiplied by this correction factor to 
produce as accurate an estimation of the number of CFUs that were present on the swabs 





Figure 2:  Technique used to estimate the surface 
area of the swab and short line inoculation, 
providing a correction factor 
Figure 3: Swab and slides used to 
estimate surface area. Tracings of the swab 
contact patches are evident in the photo. 
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To determine the survivability of each bacterial species, the initial bacterial suspensions 
CFUs/ ml had to be calculated.  This was done by dividing the highest viable plate count number 
within the statistically valid 30-300 CFUs/ ml range by the dilution factor that was plated.  This 
allowed the CFUs/ml to be calculated for each dilution in the serial dilution scheme.  The CFUs/ 
ml transferred to the slides were then determined (see Appendix I).  Using the average CFUs/ 5 
mL (per run), the percent survival of each bacterium per run was determined and averaged.   
The statistical test run on the E. coil and S. aureus survival data was a two-tailed, 
independent means t-test. Statistical significance was observed when p < 0.05. 
Section 3 
Results   
The process of transferring E. coli and S. aureus to sterile glass microscope slides 
required that these cells be air dried. The air-drying process is often associated with massive die 
off of bacterial cells (e.g., Spratt et al 2019). For all of the experiments run here the calculated 
survival of E. coli and S. aureus about 15 minutes after drying on the slides was about 12 % for 
E. coli and 30% for S. aureus (Figure 4). This result was significant (two-tailed, independent 





Figure 4: Comparison of E. coli and S. aureus Survivability after transfer to sterile glass 
microscope slides and air drying (approximately 15 minutes after the transfer). This 
difference in the survival for the two cultures was highly significant (two -tailed 
independent means t-test, p < 0.00001). 
 
 For the portion of the experiments focused on the transfer of E. coli or S. aureus from 
slides to serial dilution viable plate counts and for the line inoculations, each individual 
experiment was run in triplicate, and the values plotted in the following graphs are based on 
averages.  For a complete summary of all data collected, and calculated values for each 
experiment, see Appendix II.   
 
 
3.1       Escherichia coli 
 The agreement between line inoculation colony counts and the number of viable E. coli 
counted from the 5 ml mixed tube (CFUs/ 5ml) had an inverse relationship.  A power curve was 










Average Percent Survival on Transfer to 
Glass Slides: S. aureus vs. E. coli (+/- 1SE, n=10 for 
SA, n=13 for EC)
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count of the cells dried on the glass slides and bacterial cells represented on the short line 
inoculation (Figure 5). Note that the agreement between this trend line and the data for E. coli is 
not perfect (R2 = 0.345) . 
 E. coli equation:  Avg % Agreement = 69.233 x (Viable Cell Count of Slide)-0.326  
At higher CFUs/ 5ml on the glass slides the percent agreement between viable plate count of 
colonies from cells dried on the glass slide and colonies from the line inoculation was lower, but 
more consistent.  At lower CFUs/ 5ml, the agreement was typically higher, although variable in 
different experiments.  Therefore, bacterial samples with lower CFUs had higher agreement, 
likely due to a higher chance of survival with less competition.   
  
Figure 5: E. coli - relationship between the Average % Agreement of colony counts (comparing 
agreement between viable plate counts for cells dried on glass slides with colony counts from the 
line inoculations) and the number of dried cells on the glass slides.  
 The relationship between average line inoculation colony counts and the average number 
of viable E. coli counted on agar plates from the 5 ml mixed tube showed a potential maximum 
statistically valid limit of 35-40 CFUs from the short line inoculation (Figure 6).  An exponential 
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curve was used to best fit the data and display this maximal statistical limit for E. coli.  Note that 
the trendline and data for E. coli is not perfect (R2 = 0.411) 
E. coli equation: Avg. Viable Plate Count CFUs = 12.745e0.0456x (Avg. Line 
Inoculation CFUs) 
The trendline is linear in appearance from the 0-35 CFU short line inoculation range.  At this 
point, the trendline begins to gradually increase in slope and exponentially increases after 40 
CFUs.  The 37 CFU point from the short line inoculation could prove to be the maximal 
statistical limit for the technique.   
 
Figure 6: E. coli – relationship between average viable plate count CFUs from dried glass slides 
and average short line inoculation CFUs 
3.2      Staphylococcus aureus  
 Similar to E. coli, the agreement between line inoculation colony counts and the number 
of viable S. aureus counted from the 5 ml mixed tube (CFUs/ 5ml) on the glass slide had an 
inverse relationship.  A power curve was used to best fit the data and provide an equation to 
represent the relationship between viable plate count of the cells dried on the glass slides and 
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bacterial cells represented on a short line inoculation (Figure 7).  Note that the agreement 
between this trend line and the data for S. aureus gave a better fit than the line for E. coli (R2 = 
0.798) . 
 S. aureus equation: Avg % Agreement = 275.06 x (Viable Cell Count of Slide)-0.516  
At higher numbers of S. aureus on the slide surface the percent agreement between viable 
plate counts of colonies from cells dried on the glass slide and colonies from the line inoculation 
was lower.  At lower CFUs/ 5ml, the agreement was typically higher, although slightly variable 
in different experiments.  Therefore, bacterial samples with lower CFUs had higher agreement, 
likely due to a higher chance of survival with less competition.  This could also be due to the 
lower CFUs grown after line inoculations and more ease in counting.  Staphylococcus aureus 
showed more consistency between the two variables at both high and low concentrations of 
CFUs/ 5ml than was observed for E. coli (Figure 7).   
 
Figure 7: S. aureus - relationship between the Average % Agreement of colony counts 
(comparing agreement between viable plate counts for cells dried on glass slides with colony 
counts from the line inoculations) and the number of dried cells on the glass slides.  
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The relationship between average line inoculation colony counts and the average number 
of viable S. aureus counted on agar plates from the 5 ml mixed tube showed a potential 
maximum statistical limit of 35-40 CFUs from the short line inoculation (Figure 8).  An 
exponential curve was used to best fit the data and display this maximal statistical limit for S. 
aureus.  Note that the trendline and data for S. aureus is not perfect (R2 = 0.2057) 
S. aureus equation: Avg. Viable Plate Count CFUs = 21.063e0.0307x (Avg. Line 
Inoculation CFUs) 
The trendline is linear in appearance from the 0-35 CFU from short line inoculation range.  At 
this point, the trendline begins to gradually increase in slope and exponentially increases after 40 
CFUs.  The 37 CFU point from the short line inoculation could prove to be the maximal 
statistical limit for the technique.   
 
Figure 8: S. aureus - relationship between average viable plate count CFUs from dried glass 
slides and average short line inoculation CFUs 
3.3 Comparison of E. coli and S. aureus: Relationship Between Bacterial 
CFUs on Swab 
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 When examining the relationship between the average % agreement of the viable plate 
count of dried cells on the slide and colony count from line inoculations with the actual numbers 
of cells on the glass slides, both E. coli and S. aureus exhibited similar trends.  Lower numbers 
of cells on the glass slide resulted in better agreement between the numbers of cells counted on 
the glass slide and numbers of colonies that grew on the line inoculation. The trend lines 
converge around 10 % agreement, suggesting that when numbers of cells picked up by the swab 
are very low, factors not measured in this study may also reduce agreement between the number 
of cells picked up by the swab and colonies that grow up in a line inoculation.   
 
Figure 9: Comparison of E. coli and S. aureus - relationship between the Average % Agreement 
of colony counts (comparing the viable plate counts with the line inoculations) and the number 
of cells on the glass slides.  
 Comparing the relationship between average short line inoculation CFUs and viable plate 
count CFUs from the 5 mL mixed tube for E. coli and S. aureus together reaffirmed the maximal 
statistical limit for short line inoculations of 37 CFUs (Figure 10).  Both trendlines are linear in 
nature prior to the 35 CFUs from short line inoculations point.  At this point, the slopes for both 
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gradually increase.  At the 35-40 CFU range, the trendlines converge, suggesting that there is a 
maximal statistical limit of 37 CFUs for the short line inoculation technique.   
    
Figure 10: Comparison of E. coli and S. aureus - relationship between average viable plate 






The results for percent agreement between the viable plate counts of cells removed from 
glass slides on swabs and colony counts from swabs used for line inoculations on agar surfaces 
suggests a relationship between the number of cells picked up by a swab and the number of 
colonies that grow up after a line inoculation exists, at least for E. coli and S. aureus.  When 
higher numbers of cell CFUs/ 5ml were present on the glass slides, there was a much lower 
agreement between the numbers of colonies generated from the swabs for the viable plate counts 
and the colony counts from the short line inoculations. When lower numbers of cells were 
present on the glass slides, the relationship between number of colonies obtained from the glass 
slide and the number of colonies obtained from the line inoculations was much higher. This 
means that when lower numbers of cells on the surface were picked up by the swab, colony 
counts from the short line inoculation were more reproducible.  This relationship could be 
similar to the reason viable plate counts must be within a statistically valid range to be useable, 
where viable counts for 10 cm diameter petri dishes require colony numbers in the 30-300 CFU 
range. The surface area utilized on the agar surface for the growth of colonies will limit the 
maximal number of colonies that can be observed as being separate colonies on the petri dish.  
This relationship appears to also be true for colonies on the line inoculations. 
In an attempt to standardize a statistical limit for viable plate counts, Breed and Dotterrer 
(1916) evaluated several different limits to determine how many discrepancies per range of 
counts were present.  To do so, they plated milk samples on triplicates of agar plates at three 
different dilutions, 1:100, 1:1000, and 1:10000.  An average was taken of the CFUs counted and 
any value that was 20% or more above or below the average was listed as a discrepancy.  In 
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total, 1,435 plates were inoculated.  Of the resultant colony ranges tested, 40-200 and 30-400 had 
very similar results.  After five days of incubation, the 40-200 range had the fewest discrepancies 
by 2.9%.  However, after an additional two days of incubation (7 days total), the 30-400 range 
had the fewest discrepancies by 1.6 percent.  They determined that the two ranges (40-200, 30-
400) produced similar satisfactory results.  While the researchers did not state a specific 
standardized range, they built the framework for the current standardized statistical limit for 
viable plate counts, which is 30-300 (Breed and Dotterrer 1916).  According to Tomasiewicz et 
al. (1980), the aforementioned study is what led to the standardization of the 30-300 range.  
Tomasiewicz et al. also noted that other studies determined the counting errors to be much 
higher when the CFUs are greater than 300 (Tomasiewicz 1980).  The statistical range for viable 
plate counts is important when considering ranges of colonies produced from the line 
inoculations used in this study.  Similar to viable plate counts, the short line inoculation 
technique showed that at a certain point, the colonies became numerous and extremely difficult 
to differentiate and count, if at all possible.  Therefore, a limit to colony counts from line 
inoculations used to estimate numbers of cells present on transport slides needs to be established.   
Other limitations to the use of transport swabs to pick up bacterial cells from 
environmental surfaces exist.  When a transport swab is used to remove bacterial cells from some 
environmental surface, space available on the swab for the cells is directly related to the surface 
area of the swab coming in contact with the surface (the estimated total surface area for the 
transport swabs used in this study was approximately 355 mm2).  Therefore, as cell numbers on 
the swab surface increase (or the density of cells on the environmental surface increase) a 
saturation limit for the swab will be reached. When the swab reaches maximum capacity for 
bacteria that swab cannot pick up any additional cells.  When examining the graphs of % 
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agreement between numbers of dried cells on the slides with colonies generated from the line 
inoculations for E. coli or for S. aureus, there was an initial rapid drop-off of % agreement 
between the colony counts for the bacteria on the slide surface and the colony counts from the 
line inoculations until the trend line began to flatten out.  The points where the trend lines change 
their slope (the inflection point) may be a good indicator of where this limit is. By using data 
generated here, those limits for E. coli and S. aureus are approximately 5,000 CFU, and closer to 
10,000 CFU, respectively.  
 These limits to the use of line inoculation colony counts to relate back to CFU present on 
environmental surfaces may require further study for different species of bacteria. The two 
species studied here are very different types of bacterial cells with regard to cell wall 
composition, shape, size, and motility.  Staphylococcus aureus is a Gram-positive coccus with a 
smaller colony size and no motility.  Escherichia coli is a Gram-negative rod that is motile.  
Additionally, E. coli has a larger colony size than S. aureus.  Another point worth mentioning is 
the differential survival exhibited by both species in this study, with S. aureus being able to 
survive the drying process on the slides compared with E. coli.  All of these factors have the 
potential to play a huge role in how many CFUs result from the short line inoculation.  Such 
precautions to the use of swabs to recover viable bacterial cells from surfaces may make 
enumeration of the cells present on the surfaces via a line inoculation more reliable. For example 
to limit over-crowding of bacteria on swab surfaces, a swabbing procedure that obtains two 
swabs for two immediately adjacent sites, with one swab from an area that is ½ the surface area 
of the other swab, and comparing colony counts from the two swabs might help determine if the 
numbers obtained are valid. This would increase the time and materials needed for these studies, 
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but may represent a good first sampling regimen, adjusting future swabbing to keep the CFUs 
obtained on the swabs in the valid range for this technique.  
 The displayed relationship between the percent agreement between the viable plate 
counts of cells removed from glass slides on swabs and colonies from the short line inoculation 
is possibly related to the surface area for the bacterial colonies to grow.  The petri dishes used for 
TSA plates have a surface area of 7,854 mm2 (for a 10 cm diameter petri dish).  The short line 
inoculation plates were divided into 8 distinct sections, resulting in a surface area of no more 
than 980 mm2 per swab used.  If the same statistical limits exist between maximal colony counts 
for viable plate counts (300 colonies) and the short 5 cm line inoculations, which are made on 
approximately 1/8 of the petri dish surface = 12% of the total plate surface area, would then be = 
300 x 0.12 = 37 colonies. So, a reasonable estimate for maximal number of colonies to count 
from the line inoculations would be 37, which is close to the number of colonies counted on the 
line inoculations at the inflection points in the graphs (Figures 6, 8, and 10).   
Figures 7 and 8 examine this relationship and further demonstrate that there is a maximal 
statistically valid range for counting CFUs from the short line inoculation at 37 CFUs.  Both 
graphs exhibit an increase in slope from linear to exponential at this point which indicates that 
after this point, the short line inoculation does not accurately reflect the bacterial CFUs swabbed.  
Figure 10 reiterates this such that the trendlines converge at around 37 CFUs.  Therefore, this is 
the statistically valid maximum limit for this technique.  The contamination score ranges should 
therefore be recalculated to accommodate for this finding.   
The lower agreement between numbers of CFUs on the glass slides and the CFUs of the 
line inoculations may be related to crowding between colonies growing along the line.  The 
bacterial cells that are inoculated have limited area to grow with very high competition among 
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other cells.  It is very likely that this is another factor leading to the low percent agreement as the 
number of E. coli or S. aureus dried cells on the slides increases.   
This study also provides a good look at the survival of E. coli and S. aureus as they dry 
on a glass surface. Data presented here suggests that S. aureus is much more likely to survive on 
a surface after drying in TSB (30% survival) compared with E. coli (about 11% survival).  
Others have observed strong survival of S. aureus on surfaces. According to Landers et al. 
(2010), S. aureus has been found to survive up to 4 weeks on the surfaces of a variety of 
healthcare equipment. Spratt et al. (2019) found that S. aureus can survive on the surface of 
therapeutic ultrasound heads for up to three days, depending on the level of organic matter 
present with the cells on the heads. Whether the differential survival of E. coli and S. aureus may 
be due to physical differences in these cells (e.g., cell wall structure) is not clear.      
 One difference between E. coli and S. aureus that might help explain the differences in 
survival of these cells as the dry on the glass slides is the tolerance of these cells to drying. 
According to Pettit and Lowbury (1968), dry conditions favor the survival of Gram-positive 
cocci, such as S. aureus.  This could be an explanation as to why S. aureus had a higher 
survivability when being dried in this study.  The aforementioned study examined the survival of 
E. coli and S. aureus on glass coverslips.  The results of this study are similar to the results 
presented here; S. aureus had a higher survival when allowed to air dry on the glass coverslips 
when compared to E. coli.  This may be due to the Gram-positive cocci’s ability to survive in 
low humidity conditions.  When being dried with a filtered stream of air, there is little to no 
humidity.  Therefore, S. aureus would be expected to have a higher survival rate, as described in 





Limitations and Future Research  
 This study has provided data that can help researchers who are trying to count bacterial 
cells present on surfaces in a relatively quick, inexpensive way.  Overall, this study has 
succeeded in generating data that can help calibrate the use of a line inoculation with a swab that 
picked up bacterial cells present on a surface to determine numbers of those cells on the surface. 
There are limits to the use of this technique that appear to be related to the surface areas of both 
the swabs and the petri dish surface areas utilized for the line inoculations. When the bacteria are 
cocci, as for S. aureus in this study, the maximal number of cells on the surface that can be 
effectively counted using the line inoculation technique is about 10,000 CFU. For the larger E. 
coli bacilli (that are also motile) the reliable cut off for numbers of cells that can be effectively 
counted using this line inoculation technique is only about 5,000 CFU. Thus, if a swab has been 
saturated by high numbers of cells from a highly contaminated surface, a proposed technique to 
improve line inoculation efficiency may be to initially take two swabs from two different surface 
areas on the environmental surface being tested. If the colony counts from the line inoculations 
for the two swabs agree and the counts are < 5,000 CFU for E. coli, and < 10,000 CFU for S. 
aureus, then either surface area used for swabbing would give reliable data. If these numbers for 
the two initial swabs did not agree, then it may be necessary to repeat the process by swabbing 
smaller surface areas until the data from the two swabs agree. 
 This study was conducted in vitro and did not utilize swabs collected from a healthcare 
facility.  For example, the bacterial species tested here were placed on glass slides and quickly 
dried using a stream of filtered air.  This does not resemble a healthcare setting where the 
bacteria would be found on a variety of different surfaces, where they would be subject to a 
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variety of environmental conditions, including moisture content.  The bacteria may exhibit 
different survivability in this kind of setting compared to this study.  However, it would be 
difficult to expect to be able to replicate this study inside an actual healthcare facility (to say 
nothing about gaining Institution Review Board committee approval!), where patients and staff 
might be put at risk from the bacteria used. Therefore, it was necessary for this study to be 
conducted in vitro in a controlled environment.   
 Future research that could benefit this quick enumeration technique might involve the use 
of different bacterial species, such as Pseudomonas aeruginosa, Klebsiella pneumonia, Bacillus 
sp., and some additional Gram-positive cocci to help compare these different potential 
pathogens. Using different cell types (e.g., Gram-positive vs. Gram-negative) and both motile 
and non-motile cells will help to provide data that could improve the use of line inoculations to 
quickly count bacteria present on surfaces. Another variable that could be studied in this way 
might be the survivability and enumeration of bacteria found on dust particles. The ability of dust 
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Sample Calculations  
Experiment 9: E. coli  
Serial Dilution 5*10-7 = TMTC 5*10-8 =TMTC 5*10-9 =101 
 
A 10-1 = 212 10-2 = 31  
B 10-1 = 260 10-2 = 29 
C 10-1 = 267 10-2 =31 




Viable Plate Count vs. Line Inoculation 
CFUs/ 5 ml from plated swabs =  
A. (212/0.1)*5 = 10,600 CFUs/ 5ml 
B. (260/0.1)*5 = 13,000 CFUs/ 5ml 
C. (267/0.1)*5 = 13,350 CFUs/ 5ml 
Avg. CFUs/ 5ml = (10,600 + 13,000 + 13,350)/3 = 12316.67 CFUs/ 5ml 
Line Inoculation CFUs with correction factor =  
 65*7 = 455 CFUs 
 52*7 = 364 CFUs 
 60*7 = 420 CFUs 
Percent Agreement – Line to Swab CFU/ ml 
 (455/12316.67)*100 = 3.69% 
 (364/12326.67)*100 = 2.95% 
 (420/12316.67)*100 = 3.41% 





CFUs/ ml in original bacterial suspension = 101/ 5*10-9 = 2.02*1010 CFUs/ ml 
CFUs from Serial Dilution to Slide (CFU/0.025ml) = ((2.02*1010)*0.00005)*0.025 = 2.53*105 
Avg. CFUs/ 5ml (see above) = 12316.67 




Appendix II  
Data Collected and Calculated Values 
II.1 E. coli  
 
  
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 161
A 10^-1 167 A 10^-2 21
B 10^-1 TMTC B 10^-2 33




# in ONC Avg. VPC VPC Chart Avg. Line Line Chart From SD to slide From swab to TSB % Survivability AVG % Survival From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 34 3.40E+09 1.05E+02 1.05E+02 5.73E+01 5.73E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml AVG % Surv +/- SD AVG % Surv +/- SE cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 59 A 10^-2 5 88 49 8.50E+04 5266.666667 6.20E+00 1.25E+01 4.59E+00 1.27E+00 A 2950 5266.6667 50 350 6.64556962 7.620253 0.948143
B 10^-1 157 B 10^-2 4 161.3333333 36.33333333 B 7850 5266.6667 67 469 8.905063291
C 10^-1 100 C 10^-2 5 236.3333333 51.66666667 C 5000 5266.6667 55 385 7.310126582
4 50 113.3333333 63.33333333
5 67 246.3333333 59 % survival (EC)
6 55 117.3333333 44 6.2
105.3333333 54.33333333 6.52
132.3333333 28.66666667 From SD to slide From swab to TSB % Survivability 14.6 From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 85 8.50E+09 8.80E+01 5.80E+01 4.90E+01 35.33333333 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml 8.15 cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 36 A 10^-2 4 19.66666667 10.66666667 2.13E+05 13850 6.52E+00 10.18 1800 13850 45 315 2.274368231 2.476534 0.675569
B 10^-1 TMTC B 10^-2 63 7.666666667 3.333333333 10.74 31500 13850 67 469 3.386281588
C 10^-1 165 C 10^-2 11 12.33333333 4.333333333 4.88 8250 13850 35 245 1.768953069




From SD to slide From swab to TSB % Survivability 15.25 From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 221 10^-8 16 2.21E+09 1.61E+02 3.63E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml 14.89 cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 144 A 10^-2 20 5.53E+04 8066.666667 1.46E+01 16.67 7200 8066.6667 36 252 3.123966942 3.152893 0.10823
B 10^-1 150 B 10^-2 19 19 7500 8066.6667 38 266 3.297520661




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 58 5.80E+09 2.36E+02 5.17E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 284 A 10^-2 36 1.45E+05 11816.66667 8.15E+00 14200 11816.667 49 343 2.902679831 3.060649 0.356526
B 10^-1 245 B 10^-2 30 12250 11816.667 60 420 3.554301834




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 235 10^-8 38 2.35E+09 1.20E+02 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 131 A 10^-2 18 5.88E+04 5983.333333 1.02E+01 6550 5983.3333 58 348 5.816155989 #VALUE! #VALUE!
B 10^-1 98 B 10^-2 12 4900 5983.3333 48 288 4.813370474




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 63 6.30E+09 1.13E+02 6.33E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 TMTC A 10^-2 42 1.58E+05 16916.66667 1.07E+01 21000 16916.667 53 371 2.193103448 2.62069 0.373689
B 10^-1 265 B 10^-2 22 13250 16916.667 62 434 2.565517241




RUN 8 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 59 5.90E+09 1.28E+02 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 TMTC A 10^-2 110
B 10^-1 TMTC B 10^-2 124

















From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 5*10^-7 TMTC 5*10^-8 TMTC 5.00E-09 101 2.02E+10 2.46E+02 5.90E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 212 A 10^-2 31 2.53E+05 12316.66667 4.88E+00 10600 12316.667 65 455 3.694181326 3.35318 0.304294
B 10^-1 260 B 10^-2 29 13000 12316.667 52 364 2.955345061




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 3*10^-7 TMTC 3*10^-8 TMTC 3.00E-09 50 1.67E+10 1.17E+02 4.40E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 TMTC A 10^-2 35 1.25E+05 15766.66667 1.26E+01 17500 15766.667 49 343 2.175475687 1.953488 0.201834
B 10^-1 286 B 10^-2 23 14300 15766.667 45 315 1.997885835




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 2*10^-7 TMTC 2.00E-08 187 2*10^-9 17 9.35E+09 1.05E+02 5.43E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 106 A 10^-2 17 4.68E+04 5266.666667 1.13E+01 5300 5266.6667 58 406 7.708860759 7.221519 1.505025
B 10^-1 170 B 10^-2 19 8500 5266.6667 39 273 5.183544304




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 1.11*10^-7 TMTC 1.11E-08 205 1.11*10^-9 31 1.85E+10 1.32E+02 2.87E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 129 A 10^-2 13 5.13E+04 6616.666667 1.29E+01 6450 6616.6667 14 98 1.481108312 3.032746 1.100568
B 10^-1 118 B 10^-2 19 5900 6616.6667 35 245 3.702770781




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 5.00E-08 TMTC 5.00E-09 50 5.00E-10 4 1.00E+10 5.80E+01 3.53E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 47 A 10^-2 8 1.25E+04 2900 2.32E+01 2350 2900 42 294 10.13793103 8.528736 1.944398
B 10^-1 68 B 10^-2 8 3400 2900 24 168 5.793103448




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 2.00E-08 258 2.00E-09 25 2.00E-10 3 1.29E+10 1.97E+01 1.07E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 16 A 10^-2 2 6.45E+03 983.3333333 1.52E+01 800 983.33333 15 105 10.6779661 7.59322 2.982666
B 10^-1 26 B 10^-2 1 1300 12 84 8.542372881




From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 1.43E-08 103 1.43E-09 11 1.43E-10 0 7.20E+09 7.67E+00 3.33E+00 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 8 A 10^-2 3 2.58E+03 383.3333333 1.49E+01 400 383.33333 1 7 1.826086957 6.086957 4.792874
B 10^-1 8 B 10^-2 0 400 7 49 12.7826087




From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 1.43E-08 148 1.43E-09 22 1.43E-10 1 1.03E+10 12.33333333 4.333333333 From SD to slide From swab to TSB % Survivability cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 14 A 10^-2 1 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml 700 616.66667 6 42 6.810810811 4.918919 1.929359
B 10^-1 13 B 10^-2 0 3.70E+03 616.6666667 1.67E+01 650 5 35 5.675675676




From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 2.00E-08 207 2.00E-09 22 2.00E-10 2.00E+00 1.04E+10 19.66666667 10.33333333 From SD to slide From swab to TSB % Survivability cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 19 A 10^-2 3 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml 950 983.33333 12 84 8.542372881 7.355932 2.746809
B 10^-1 19 B 10^-2 1 5.18E+03 983.3333333 1.90E+01 950 5 35 3.559322034



















# in ONC Avg. Line Line Chart Avg. VPC VPC Chart
RUN 1 From SD to slide From swab to TSB % Survivability AVG % SurvivalAVG % Surv +/- SD AVG % Surv +/- SE From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 47 10^-8 3 4.70E+08 4.03E+01 4.03E+01 8.93E+01 89.33333333 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml 3.07E+01 9.45E+00 2.99E+00 cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 135 A 10^-2 12 15.33333333 56.33333333 1.18E+04 4466.666667 3.80E+01 6750 4466.66667 30 210 4.701492537 6.320895522 1.229555
B 10^-1 37 B 10^-2 0 54.33333333 142.3333333 1850 4466.66667 42 294 6.582089552
C 10^-1 96 C 10^-2 9 82.33333333 138 4800 4466.66667 49 343 7.679104478
1 30 62 54
2 42 53 180.6666667
3 49 35.33333333 230.6666667
26 113
RUN 2 24.33333333 37 From SD to slide From swab to TSB % Survivability % surv. (SA) From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 248 10^-7 31 10^-8 3 2.48E+08 1.53E+01 4.67E+00 5.63E+01 14.33333333 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml 38.01 cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 45 A 10^-2 4 3.666666667 10.66666667 6.20E+03 2816.666667 4.54E+01 45.43 2250 2816.66667 13 91 3.230769231 3.810650888 0.422404
B 10^-1 87 B 10^-2 6 17.33333333 36.33333333 17.57 4350 2816.66667 16 112 3.976331361





RUN 3 From SD to slide From swab to TSB % Survivability 20.56 From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 169 1.69E+10 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml 25.6 cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 TMTC A 10^-2 145 4.23E+05 37.43
B 10^-1 TMTC B 10^-2 294 30.03




RUN 4 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 162 1.62E+10 5.43E+01 1.42E+02 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 TMTC A 10^-2 229 4.05E+05 71166.66667 1.76E+01 114500 71166.6667 52 364 0.51147541 0.53442623 0.047058
B 10^-1 TMTC B 10^-2 78 39000 71166.6667 61 427 0.6




RUN 5 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-6 TMTC 10^-7 TMTC 10^-8 119 1.19E+10 8.23E+01 1.38E+02 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 TMTC A 10^-2 149 2.98E+05 69000 2.32E+01 74500 69000 78 546 0.791304348 0.8352657 0.048536
B 10^-1 TMTC B 10^-2 138 69000 69000 80 560 0.811594203




RUN 6 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 3*10^-7 TMTC 3*10^-8 TMTC 3.00E-09 43 1.43E+10 6.20E+01 5.40E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 TMTC A 10^-2 38 1.08E+05 27000 2.51E+01 19000 27000 71 497 1.840740741 1.607407407 0.173271
B 10^-1 TMTC B 10^-2 60 30000 27000 55 385 1.425925926




RUN 7 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 2*10^-7 TMTC 2.00E-08 164 2*10^-9 22 8.20E+09 5.30E+01 1.81E+02 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 293 A 10^-2 28 4.10E+04 14433.33333 3.52E+01 14650 14433.3333 51 357 2.473441109 2.570438799 0.285553
B 10^-1 TMTC B 10^-2 36 18000 14433.3333 47 329 2.279445727






RUN 8 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 1.43*10^-7 TMTC 1.43E-08 105 1.43*10^-9 17 7.34E+09 3.53E+01 2.31E+02 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 261 A 10^-2 17 2.62E+04 11533.33333 4.40E+01 13050 11533.3333 28 196 1.699421965 2.144508671 0.348071
B 10^-1 214 B 10^-2 29 10700 11533.3333 42 294 2.549132948




RUN 9 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 10^-7 TMTC 10^-8 94 10^-9 13 9.40E+09 2.60E+01 1.13E+02 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 134 A 10^-2 16 2.35E+04 5650 2.40E+01 6700 5650 27 189 3.345132743 3.221238938 1.065775
B 10^-1 91 B 10^-2 9 4550 5650 15 105 1.85840708




RUN 10 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 5.00E-08 TMTC 5.00E-09 36 5.00E-10 6 7.20E+09 2.43E+01 3.70E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 42 A 10^-2 4 9.00E+03 1850 2.06E+01 2100 1850 15 105 5.675675676 9.207207207 2.936329
B 10^-1 22 B 10^-2 1 1100 1850 24 168 9.081081081




RUN 11 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 2.00E-08 112 2.00E-09 14 2.00E-10 0 5.60E+09 4.67E+00 1.43E+01 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 13 A 10^-2 0 2.80E+03 716.6666667 2.56E+01 650 716.666667 5 35 4.88372093 4.558139535 0.460442
B 10^-1 18 B 10^-2 1 900 716.666667 5 35 4.88372093




RUN 12 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 1.43E-08 57 1.43E-09 5 1.43E-10 0 3.99E+09 3.666666667 10.66666667 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 10 A 10^-2 0 1.43E+03 533.3333333 3.74E+01 500 533.333333 2 14 2.625 4.8125 3.093592
B 10^-1 14 B 10^-2 0 700 533.333333 2 14 2.625




RUN 13 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 2.00E-08 242 2.00E-09 26 2.00E-10 0 1.21E+10 17.33333333 36.33333333 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 35 A 10^-2 4 6.05E+03 1816.666667 3.00E+01 1750 1816.66667 14 98 5.394495413 6.678899083 1.816421
B 10^-1 33 B 10^-2 3 1650 1816.66667 14 98 5.394495413




RUN 14 From SD to slide From swab to TSB % Survivability From Swab From Swab Line Inoc Line Inoc Percent Agreement AVG % Agreement
SD: 1.43E-08 87 1.43E-09 7 1.43E-10 0 6083916084 6 14.33333333 cfu/ 0.025ml cfu/ 5 ml (AVG) Swab to SD cfu/ ml cfu/5ml AVG cfu Correction Line to Swab cfu/ml  +/- SD
A 10^-1 11 A 10^-2 0 2175 716.6666667 32.95019157 550 716.666667 3 21 2.930232558 5.860465116 2.392525
B 10^-1 16 B 10^-2 4 800 716.666667 6 42 5.860465116
C 10^-1 16 C 10^-2 1 800 716.666667 9 63 8.790697674
40 3
41 6
42 9
